Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Illumina Inc
(NQ:
ILMN
)
124.93
+0.10 (+0.08%)
Streaming Delayed Price
Updated: 2:53 PM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Illumina Inc
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Illumina Unusual Options Activity For May 07
May 07, 2024
Via
Benzinga
Beyond The Numbers: 6 Analysts Discuss Illumina Stock
May 03, 2024
Via
Benzinga
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
May 03, 2024
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report.
Via
Benzinga
ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
ILMN stock results show that Illumina beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Looking Into Illumina's Recent Short Interest
April 12, 2024
Via
Benzinga
Critical Insights From Illumina Analyst Ratings: What You Need To Know
February 14, 2024
Via
Benzinga
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
May 02, 2024
U.S. stocks look to push ahead on a positive path, now that the Federal Reserve’s rate decision is in the rearview mirror. Major index futures point to a positive open on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
May 02, 2024
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.
Via
InvestorPlace
Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'
April 30, 2024
Jim Cramer doesn't recommend buying Dynatrace stock due to its high price. Canopy Growth is the best pot stock. BrightSpring, Illumina, and Bank of America also mentioned. Cramer recommends buying Palo...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
April 16, 2024
Investing with the Ark Invest guru is a roller coaster ride, but she always keeps her big ideas for the future in front of her.
Via
InvestorPlace
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
April 08, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Via
Benzinga
Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
April 05, 2024
Investors might want to be wary and dump these expensive Nasdaq stocks to sell before their impending and potentially violent corrections.
Via
InvestorPlace
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
March 31, 2024
Over the past 12 months, 10 Large-Cap stocks have underperformed all others.
Via
Talk Markets
Why Illumina Stock Zoomed Higher on Thursday
March 21, 2024
The company's chances for winning an important legal battle have improved dramatically.
Via
The Motley Fool
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
March 21, 2024
EU antitrust advisor criticizes decision blocking Illumina's $7.1 billion bid for Grail, citing overreach. Impact on Qualcomm deal scrutinized. Commission's jurisdiction challenged amid legal battles....
Via
Benzinga
Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On
March 18, 2024
Carl Icahn, the corporate raider turned activist investor, has put most of his master limited partnership' portfolio into just three stocks.
Via
InvestorPlace
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
March 13, 2024
Carl Icahn halts new challenge to Illumina's board, sparing the gene sequencing giant a second proxy battle. Focus shifts to legal action over Grail acquisition.
Via
Benzinga
Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars
March 11, 2024
Although there were many earnings winners in the fourth quarter, these three picks have more promise than their counterparts.
Via
InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.
Via
InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
March 05, 2024
Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine.
Via
InvestorPlace
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
February 27, 2024
Although U.S. stocks closed lower on Monday, there were a few notable insider trades.
Via
Benzinga
Why Illumina Stock Mashed the Market on Monday
February 26, 2024
Investors usually get more bullish when a top manager buys more heavily into their company.
Via
The Motley Fool
Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024
February 23, 2024
For those who want to invest alongside the legendary financier and activist investor, these are the top Carl Icahn stocks right now.
Via
InvestorPlace
3 Gene Editing Stocks With Unprecedented Surge Potential
February 13, 2024
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.
Via
InvestorPlace
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 09, 2024
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session following third-quarter results.
Via
Benzinga
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
February 09, 2024
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.
Via
Benzinga
US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March
February 09, 2024
The upward momentum that has been in play in recent sessions could cushion the market, especially as most major indices are in uncharted territory.
Via
Benzinga
Expedia Reports Q4 Results, Joins Pinterest, Affirm Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
February 09, 2024
U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 15 points on Friday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
S&P 500 Tests Resistance At 5,000, ARM Rockets, Oil Rebounds: What's Driving Markets Thursday?
February 08, 2024
Major U.S. stock averages traded on a mixed note at midday in New York, with the S&P 500 grappling with the psychological resistance level of 5,000, while the tech-heavy Nasdaq 100 managed to reach...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.